[Percutaneous transluminal angioplasty (PTA) of peripheral arteries with drug-eluting balloon (DEB)]

Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
Record ID 32015000948
German
Authors' objectives: This systematic review assesses the efficacy and safety of percutaneous transluminal angioplasty (PTA) with drug-eluting balloon (DEB) compared to PTA with uncoated balloon (UCB) for the treatment of peripheral artery disease (PAD) of various vascular regions. However, only studies evaluating the intervention in patients with PAD of the lower extremities were identified. This systematic review is the first update of the systematic review published in 2013.
Authors' recommendations: The available evidence indicates that PTA with DEB for patients with PAD (Rutherford category ≥3) in femoropopliteal arteries is more effective and not less safe than PTA with UCB. The inclusion in the catalogue of benefits is recommended with restrictions (because of missing long-term results). The available evidence is insufficient to assess the efficacy and safety of PTA with DEB for PAD in infrapopliteal arteries. The inclusion in the catalogue of benefits is currently not recommended. Due to several ongoing studies, we suggest a re-evaluation in 2017.
Details
Project Status: Completed
URL for project: http://hta.lbg.ac.at/page/bewertung-medizinischer-einzelleistungen-mel-2015
Year Published: 2015
URL for published report: http://eprints.hta.lbg.ac.at/1057/1/DSD_68_Update2015.pdf
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Austria
MeSH Terms
  • Angioplasty
  • Angioplasty, Balloon
  • Femoral Artery
  • Peripheral Arterial Disease
  • Coated Materials, Biocompatible
Contact
Organisation Name: Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address: Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name: tarquin.mittermayr@aihta.at
Contact Email: office@aihta.at
Copyright: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.